Observational Study on the Impact of Herpes Zoster Vaccine on the Incidence of Herpes Zoster and Survival in Lung Cancer Patients

Guangzhou Medical University

Status: Not yet enrolling

Conditions: Lung Cancer

Treatments: Biological: herpes zoster vaccine

Study type: Observational

Funder types: Other

Identifiers

NCT07170059

ZSHV-LC-OBS2025

Details and patient eligibility

About

To evaluate the impact of herpes zoster vaccine on the incidence of herpes zoster and survival in lung cancer patients, and to explore its preventive effect and safety.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 1.Male or female patients >=18 years of age; 2.Histological diagnosis of NSCLC, including both non-small cell lung cancer and small cell lung cancer, regardless of whether they are in the early, locally advanced stage or advanced stage, and regardless of whether they have received surgery, radiotherapy, chemotherapy or other treatments; 3. Never received herpes zoster vaccine

Exclusion criteria

• Patients having other factors that preventing researchers from enrollment them.

Trial design

500 participants in 2 patient groups

Vaccination group

Description:

Lung cancer patients receive herpes zoster vaccine

Treatment:

Biological: herpes zoster vaccine

Unvaccinated group

Description:

Lung cancer patients have not received herpes zoster vaccine